Select Medical Holdings Corporation Forecast, price target & analysts
Select Medical Holdings Corporation Target price 2025 - Analyst rating & recommendation
Select Medical Holdings Corporation Classifications & Recommendation:
Select Medical Holdings Corporation Price Target
| Target Price | $22.80 |
| Price | $18.46 |
| Potential |
23.51%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Select Medical Holdings Corporation 2026 .
The average Select Medical Holdings Corporation target price is $22.80.
This is
23.51%
register free of charge
$25.00
35.43%
register free of charge
$19.00
2.93%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Select Medical Holdings Corporation to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Select Medical Holdings Corporation stock has an average upside potential 2026 of
23.51%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.19 | 5.47 |
| 7.48% | 5.51% | |
| EBITDA Margin | 7.86% | 9.67% |
| 5.49% | 23.01% | |
| Net Margin | 4.13% | 2.67% |
| 19.14% | 35.30% |
5 Analysts have issued a sales forecast Select Medical Holdings Corporation 2025 . The average Select Medical Holdings Corporation sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Select Medical Holdings Corporation EBITDA forecast 2025. The average Select Medical Holdings Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Select Medical Holdings Corporation Analysts have issued a net profit forecast 2025. The average Select Medical Holdings Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.66 | 1.13 |
| 13.09% | 31.93% | |
| P/E | 16.29 | |
| EV/Sales | 0.98 |
4 Analysts have issued a Select Medical Holdings Corporation forecast for earnings per share. The average Select Medical Holdings Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Select Medical Holdings Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Select Medical Holdings Corporation...
Current Select Medical Holdings Corporation Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital | Locked ➜ Locked | Locked | Feb 24 2025 |
| UBS | Locked ➜ Locked | Locked | Jan 03 2025 |
| Benchmark | Locked ➜ Locked | Locked | Nov 25 2024 |
| Benchmark | Locked ➜ Locked | Locked | Nov 04 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Nov 04 2024 |
| Benchmark | Locked ➜ Locked | Locked | Nov 01 2024 |
| Benchmark | Locked ➜ Locked | Locked | Sep 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital: Locked ➜ Locked
|
Feb 24 2025 |
|
Locked
UBS: Locked ➜ Locked
|
Jan 03 2025 |
|
Locked
Benchmark: Locked ➜ Locked
|
Nov 25 2024 |
|
Locked
Benchmark: Locked ➜ Locked
|
Nov 04 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Nov 04 2024 |
|
Locked
Benchmark: Locked ➜ Locked
|
Nov 01 2024 |
|
Locked
Benchmark: Locked ➜ Locked
|
Sep 06 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
